Rebecca W. Beerman

Rebecca W. Beerman

Auto-generated profile, based on publicly available information

Rebecca W. Beerman

C Office of Scientific Integrity , Duke University , Durham , NC , USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2014 in Nature
Verified
Journal Article
Open access
PDF file
SOStefan Oehlers
Stefan Oehlers
MCMark R. Cronan
Mark R. Cronan
NSNinecia R. Scott
Ninecia R. Scott
MTMonica I. Thomas
Monica I. Thomas
KOKazuhide Shaun Okuda
Kazuhide Shaun Okuda
DTDavid M. Tobin
David M. Tobin
Using a model of tuberculosis in zebrafish, granuloma formation is shown to coincide with hypoxia and angiogenesis; furthermore, the pharmacological inhibition of the pro-angiogenic VEGF pathway reduces infection burden, suggesting a possible treatment strategy in patients with the disease. Tuberculosis infections are often associated with the generation of masses of inflamed tissue known as tuberculous granulomas. Using intravital imaging in the zebrafish–Mycobacterium marinum infection model, this study shows that granuloma formation coincides with hypoxia and the induction of the pro-angiogenic molecule VEGF. Pharmacological inhibition of the VEGF pathway prevents vascularization of the granuloma tissue and reduces infection burden. Anti-angiogenic therapies also synergize with anti-tubercular treatments, suggesting possible alternatives to conventional therapy in the event of antibiotic resistance. Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis1,2. Here we examine the development and consequences of vascularization of the tuberculous granuloma in the zebrafish–Mycobacterium marinum infection model, which is characterized by organized granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis2. Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule Vegfaa. Pharmacological inhibition of the Vegf pathway suppresses granuloma-associated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergize with the first-line anti-tubercular antibiotic rifampicin, as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations3. Our data indicate that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of anti-angiogenic agents, now being used in cancer regimens, as a host-targeting tuberculosis therapy, particularly in extensively drug-resistant disease for which current antibiotic regimens are largely ineffective.

1 October 2016 in Immunity
Verified
Journal Article
Closed access
MCMark R. Cronan
Mark R. Cronan
RBRebecca W. Beerman
Rebecca W. Beerman
ARAllison F. Rosenberg
Allison F. Rosenberg
JSJoseph W. Saelens
Joseph W. Saelens
MJMatthew G. Johnson
Matthew G. Johnson
DTDavid M. Tobin
David M. Tobin

17 February 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Lindsay MarjoramLindsay Marjoram
Lindsay Marjoram
AAAshley Alvers
Ashley Alvers
MDM. Elizabeth Deerhake
M. Elizabeth Deerhake
JBJennifer Bagwell
Jennifer Bagwell
JMJamie Mankiewicz
Jamie Mankiewicz
MBMichel Bagnat
Michel Bagnat
The intestinal epithelium forms a barrier protecting the organism from microbes and other proinflammatory stimuli. The integrity of this barrier and the proper response to infection requires precise regulation of powerful immune homing signals such as tumor necrosis factor (TNF). Dysregulation of TNF leads to inflammatory bowel diseases (IBD), but the mechanism controlling the expression of this potent cytokine and the events that trigger the onset of chronic inflammation are unknown. Here, we show that loss of function of the epigenetic regulator ubiquitin-like protein containing PHD and RING finger domains 1 (uhrf1) in zebrafish leads to a reduction in tnfa promoter methylation and the induction of tnfa expression in intestinal epithelial cells (IECs). The increase in IEC tnfa levels is microbe-dependent and results in IEC shedding and apoptosis, immune cell recruitment, and barrier dysfunction, consistent with chronic inflammation. Importantly, tnfa knockdown in uhrf1 mutants restores IEC morphology, reduces cell shedding, and improves barrier function. We propose that loss of epigenetic repression and TNF induction in the intestinal epithelium can lead to IBD onset.

7 October 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EWEric M. Walton
Eric M. Walton
MCMark R. Cronan
Mark R. Cronan
RBRebecca W. Beerman
Rebecca W. Beerman
DTDavid M. Tobin
David M. Tobin
Transgenic labeling of innate immune cell lineages within the larval zebrafish allows for real-time, in vivo analyses of microbial pathogenesis within a vertebrate host. To date, labeling of zebrafish macrophages has been relatively limited, with the most specific expression coming from the mpeg1 promoter. However, mpeg1 transcription at both endogenous and transgenic loci becomes attenuated in the presence of intracellular pathogens, including Salmonella typhimurium and Mycobacterium marinum. Here, we describe mfap4 as a macrophage-specific promoter capable of producing transgenic lines in which transgene expression within larval macrophages remains stable throughout several days of infection. Additionally, we have developed a novel macrophage-specific Cre transgenic line under the control of mfap4, enabling macrophage-specific expression using existing floxed transgenic lines. These tools enrich the repertoire of transgenic lines and promoters available for studying zebrafish macrophage dynamics during infection and inflammation and add flexibility to the design of future macrophage-specific transgenic lines.

29 January 2019 in eLife
Verified
Journal Article
Open access
MMMolly A Matty
Molly A Matty
DKDaphne R Knudsen
Daphne R Knudsen
EWEric M Walton
Eric M Walton
RBRebecca W Beerman
Rebecca W Beerman
MCMark R Cronan
Mark R Cronan
DTDavid M Tobin
David M Tobin
Mycobacterium tuberculosis is the leading worldwide cause of death due to a single infectious agent. Existing anti-tuberculous therapies require long treatments and are complicated by multi-drug-resistant strains. Host-directed therapies have been proposed as an orthogonal approach, but few have moved into clinical trials. Here, we use the zebrafish-Mycobacterium marinum infection model as a whole-animal screening platform to identify FDA-approved, host-directed compounds. We identify multiple compounds that modulate host immunity to limit mycobacterial disease, including the inexpensive, safe, and widely used drug clemastine. We find that clemastine alters macrophage calcium transients through potentiation of the purinergic receptor P2RX7. Host-directed drug activity in zebrafish larvae depends on both P2RX7 and inflammasome signaling. Thus, targeted activation of a P2RX7 axis provides a novel strategy for enhanced control of mycobacterial infections. Using a novel explant model, we find that clemastine is also effective within the complex granulomas that are the hallmark of mycobacterial infection.

1 December 2015 in Cell Reports
Verified
Journal Article
Open access
RBRebecca W. Beerman
Rebecca W. Beerman
MMMolly A. Matty
Molly A. Matty
GAGina G. Au
Gina G. Au
LLLoren L. Looger
Loren L. Looger
KCKingshuk Roy Choudhury
Kingshuk Roy Choudhury
DTDavid M. Tobin
David M. Tobin
Calcium signaling has long been associated with key events of immunity, including chemotaxis, phagocytosis, and activation. However, imaging and manipulation of calcium flux in motile immune cells in live animals remain challenging. Using light-sheet microscopy for in vivo calcium imaging in zebrafish, we observe characteristic patterns of calcium flux triggered by distinct events, including phagocytosis of pathogenic bacteria and migration of neutrophils toward inflammatory stimuli. In contrast to findings from ex vivo studies, we observe enriched calcium influx at the leading edge of migrating neutrophils. To directly manipulate calcium dynamics in vivo, we have developed transgenic lines with cell-specific expression of the mammalian TRPV1 channel, enabling ligand-gated, reversible, and spatiotemporal control of calcium influx. We find that controlled calcium influx can function to help define the neutrophil's leading edge. Cell-specific TRPV1 expression may have broad utility for precise control of calcium dynamics in other immune cell types and organisms.